Key Metrics
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.88
5-Year SI
5-year SI
- N/A 2-year SI
- 0.92 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- P53 pathway
- Bone marrow
- Lung cancer
- Head and neck
- Glioblastoma
- DNA damage
- Breast cancer
- Tumor microenvironment
- Drug delivery
- Epidermal growth factor receptor
- Extracellular vesicles
- Cisplatin
- Mathematical model
- Neuroblastoma
- Gene expression
- Prostate cancer
- Bystander effect
- Overall survival
- Hepatocellular carcinoma
Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in NEOPLASIA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia
- 26 Oct 21
- Neoplasia
-
Full paper
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation
- 21 Oct 21
- Neoplasia
-
Full paper
Retraction notice to <Recruitment of Tiam1 to Semaphorin 4D activates Rac and enhances proliferation, invasion and metastasis in oral squamous cell carcinoma> <[Neoplasia 19 (2016) 65-74]>
- 1 Aug 21
- Neoplasia
-
Full paper
Correction
- 1 Oct 13
- Neoplasia
-
Full paper
Correction
- 1 Oct 13
- Neoplasia
-
Full paper
Correction
- 1 Oct 13
- Neoplasia
Scite analysis
Powered by scite_
2.5k articles received 120.5k citations see all
- 5,442 Supporting
- 113,367 Mentioning
- 471 Contrasting
Editorial notices
- 7 Retractions
- 1 Withdrawals
- 0 Corrections
- 35 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
44%
4 to 6 months
48%
7 to 9 months
8%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has NEOPLASIA been actively publishing?
NEOPLASIA has been in operation since 1999 till date.
What is the publishing frequency of NEOPLASIA ?
NEOPLASIA published with a Monthly frequency.
How many articles did NEOPLASIA publish last years ?
In 2023, NEOPLASIA published articles.
What is the eISSN & pISSN for NEOPLASIA ?
For NEOPLASIA,eISSN is 1476-5586 and pISSN is1476-5586.
Who is the publisher of NEOPLASIA ?
ELSEVIER SCIENCE INC is the publisher of NEOPLASIA.